Koninklijke Philips Total Liabilities 2010-2024 | PHG

Koninklijke Philips total liabilities from 2010 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
  • Koninklijke Philips total liabilities for the quarter ending September 30, 2024 were $18.905B, a 7.81% decline year-over-year.
  • Koninklijke Philips total liabilities for 2023 were $18.772B, a 2.37% increase from 2022.
  • Koninklijke Philips total liabilities for 2022 were $18.338B, a 5.98% decline from 2021.
  • Koninklijke Philips total liabilities for 2021 were $19.505B, a 7.99% increase from 2020.
Koninklijke Philips Annual Total Liabilities
(Millions of US $)
2023 $18,772
2022 $18,338
2021 $19,505
2020 $18,062
2019 $16,118
2018 $16,418
2017 $15,024
2016 $20,799
2015 $21,315
2014 $23,109
2013 $20,366
2012 $23,028
2011 $23,088
2010 $22,811
2009 $22,219
Koninklijke Philips Quarterly Total Liabilities
(Millions of US $)
2024-06-30 $18,905
2023-06-30 $18,915
2023-03-31
2022-06-30 $18,862
2021-06-30 $20,507
2020-06-30 $18,170
2019-06-30 $16,207
2018-06-30 $15,650
2017-06-30 $17,253
2016-12-31 $20,799
2016-09-30 $20,566
2016-06-30 $21,177
2016-03-31 $20,242
2015-12-31 $21,315
2015-09-30 $20,733
2015-06-30 $21,434
2015-03-31 $22,909
2014-12-31 $23,109
2014-09-30 $22,450
2014-06-30 $20,441
2014-03-31 $20,488
2013-12-31 $20,366
2013-09-30 $21,691
2013-06-30 $21,969
2013-03-31 $23,154
2012-12-31 $23,028
2012-09-30 $21,269
2012-06-30 $21,888
2012-03-31 $22,743
2011-12-31 $23,088
2011-09-30 $20,916
2011-06-30 $20,179
2011-03-31 $21,669
2010-12-31 $22,811
2010-09-30 $21,441
2010-06-30 $23,630
2010-03-31 $23,849
2009-12-31 $22,219
2009-09-30 $22,834
2009-06-30 $21,411
2009-03-31 $21,725
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $23.527B $19.663B
Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $194.987B 24.87
Stryker (SYK) United States $136.147B 30.68
Boston Scientific (BSX) United States $130.670B 37.57
EssilorLuxottica (ESLOY) France $110.026B 0.00
Medtronic (MDT) Ireland $102.570B 15.24
Haleon (HLN) United Kingdom $43.909B 28.53
Lonza Group Ag (LZAGY) Switzerland $42.293B 0.00
GE HealthCare Technologies (GEHC) United States $35.376B 18.35
ResMed (RMD) United States $33.995B 27.93
Terumo (TRUMY) Japan $28.800B 40.67
Zimmer Biomet Holdings (ZBH) United States $21.064B 13.41
Insulet (PODD) United States $17.996B 71.67
Baxter (BAX) United States $14.756B 9.60
Smith & Nephew SNATS (SNN) United Kingdom $10.838B 0.00
BellRing Brands (BRBR) United States $10.021B 40.32
Bio-Rad Laboratories (BIO) United States $9.125B 31.01
Demant (WILYY) Denmark $7.926B 0.00
Lantheus Holdings (LNTH) United States $6.392B 14.85
Prestige Consumer Healthcare (PBH) United States $3.886B 19.33
Haemonetics (HAE) United States $3.862B 18.85
ICU Medical (ICUI) United States $3.751B 35.71
Perrigo (PRGO) Ireland $3.510B 10.33
Envista Holdings (NVST) United States $3.103B 23.11
Shandong Weigao Medical Polymer (SHWGF) China $3.010B 0.00
QuidelOrtho (QDEL) United States $2.894B 18.63
GN Store Nord (GNNDY) Denmark $2.864B 18.36
Neogen (NEOG) United States $2.605B 30.05
LeMaitre Vascular (LMAT) United States $2.074B 50.41
Green Thumb Industries (GTBIF) United States $1.630B 28.52
AtriCure (ATRC) United States $1.465B 0.00
InMode (INMD) Israel $1.444B 8.68
Maravai LifeSciences Holdings (MRVI) United States $1.371B 0.00
AdaptHealth (AHCO) United States $1.304B 9.32
BioLife Solutions (BLFS) United States $1.211B 0.00
Owens & Minor (OMI) United States $0.973B 7.60
CeriBell (CBLL) United States $0.958B 0.00
Curaleaf Holdings (CURLF) Canada $0.955B 0.00
Phibro Animal Health (PAHC) United States $0.883B 15.58
Evolus (EOLS) United States $0.688B 0.00
Omeros (OMER) United States $0.593B 0.00
VAREX IMAGING (VREX) United States $0.593B 26.15
Capricor Therapeutics (CAPR) United States $0.587B 0.00
Surmodics (SRDX) United States $0.572B 0.00
Verano Holdings (VRNOF) United States $0.445B 0.00
Cresco Labs (CRLBF) United States $0.429B 0.00
Quanterix (QTRX) United States $0.383B 0.00
ZimVie (ZIMV) United States $0.373B 31.44
Valneva SE (VALN) France $0.353B 0.00
Biote (BTMD) United States $0.313B 6.86
Viemed Healthcare (VMD) United States $0.312B 29.70
Canopy Growth (CGC) Canada $0.295B 0.00
Cerus (CERS) United States $0.293B 0.00
OraSure Technologies (OSUR) United States $0.283B 18.95
Sanara MedTech (SMTI) United States $0.276B 0.00
Zynex (ZYXI) United States $0.268B 56.00
High Tide (HITI) Canada $0.237B 98.00
Aurora Cannabis (ACB) Canada $0.225B 0.00
Utah Medical Products (UTMD) United States $0.211B 14.54
MacroGenics (MGNX) United States $0.200B 0.00
Sanuwave Health (SNWV) United States $0.188B 2.64
Organigram Holdings (OGI) Canada $0.184B 0.00
TerrAscend (TSNDF) Canada $0.181B 0.00
Brainsway (BWAY) Israel $0.169B 89.60
FitLife Brands (FTLF) United States $0.151B 19.04
Jin Medical (ZJYL) China $0.132B 0.00
TriSalus Life Sciences (TLSI) United States $0.110B 0.00
Quipt Home Medical (QIPT) United States $0.104B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.100B 0.00
Fonar (FONR) United States $0.096B 10.79
Veru (VERU) United States $0.092B 0.00
Exagen (XGN) United States $0.083B 0.00
Rockwell Medical (RMTI) United States $0.066B 34.17
InterCure (INCR) Israel $0.061B 0.00
Apyx Medical (APYX) United States $0.059B 0.00
Jushi Holdings (JUSHF) United States $0.054B 0.00
Modular Medical (MODD) United States $0.050B 0.00
Cytosorbents (CTSO) United States $0.048B 0.00
Safety Shot (SHOT) United States $0.042B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
Allurion Technologies (ALUR) United States $0.018B 0.00
Nephros (NEPH) United States $0.016B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Innovative Eyewear (LUCY) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
Meihua Medical Technologies (MHUA) China $0.008B 0.00
Trinity Biotech (TRIB) Ireland $0.006B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
Agape ATP (ATPC) $0.005B 0.00
IM Cannabis (IMCC) Canada $0.004B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Sharps Technology (STSS) United States $0.003B 0.00
Senestech (SNES) United States $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.001B 0.00
United-Guardian (UG) United States $0.000B 12.82
SNDL (SNDL) Canada $0.000B 0.00